These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25214320)

  • 1. Impact of common risk factors of fibrosis progression in chronic hepatitis C.
    Rüeger S; Bochud PY; Dufour JF; Müllhaupt B; Semela D; Heim MH; Moradpour D; Cerny A; Malinverni R; Booth DR; Suppiah V; George J; Argiro L; Halfon P; Bourlière M; Talal AH; Jacobson IM; Patin E; Nalpas B; Poynard T; Pol S; Abel L; Kutalik Z; Negro F
    Gut; 2015 Oct; 64(10):1605-15. PubMed ID: 25214320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Fibrosis Progression Rate in Patients with Chronic Hepatitis C Genotype 4: Role of Cirrhosis Risk Score and Host Factors.
    Besheer T; El-Bendary M; Elalfy H; Abd El-Maksoud M; Salah M; Zalata K; Elkashef W; Elshahawy H; Raafat D; Elemshaty W; Almashad N; Zaghloul H; El-Gilany AH; Abdel Razek AA; Abd Elwahab M
    J Interferon Cytokine Res; 2017 Mar; 37(3):97-102. PubMed ID: 28068153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.
    Bochud PY; Cai T; Overbeck K; Bochud M; Dufour JF; Müllhaupt B; Borovicka J; Heim M; Moradpour D; Cerny A; Malinverni R; Francioli P; Negro F;
    J Hepatol; 2009 Oct; 51(4):655-66. PubMed ID: 19665246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.
    Patin E; Kutalik Z; Guergnon J; Bibert S; Nalpas B; Jouanguy E; Munteanu M; Bousquet L; Argiro L; Halfon P; Boland A; Müllhaupt B; Semela D; Dufour JF; Heim MH; Moradpour D; Cerny A; Malinverni R; Hirsch H; Martinetti G; Suppiah V; Stewart G; Booth DR; George J; Casanova JL; Bréchot C; Rice CM; Talal AH; Jacobson IM; Bourlière M; Theodorou I; Poynard T; Negro F; Pol S; Bochud PY; Abel L; ;
    Gastroenterology; 2012 Nov; 143(5):1244-1252.e12. PubMed ID: 22841784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of obesity to hepatitis C-related fibrosis progression.
    Ortiz V; Berenguer M; Rayón JM; Carrasco D; Berenguer J
    Am J Gastroenterol; 2002 Sep; 97(9):2408-14. PubMed ID: 12358265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
    Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL
    J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C.
    Howell J; Sawhney R; Angus P; Fink M; Jones R; Wang BZ; Visvanathan K; Crowley P; Gow P
    Transpl Infect Dis; 2013 Dec; 15(6):588-99. PubMed ID: 24028328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
    Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
    Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens.
    Tamaki N; Kurosaki M; Higuchi M; Takada H; Nakakuki N; Yasui Y; Suzuki S; Tsuchiya K; Nakanishi H; Itakura J; Takahashi Y; Ogawa S; Tanaka Y; Asahina Y; Izumi N
    PLoS One; 2015; 10(9):e0137351. PubMed ID: 26352693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.
    Mandorfer M; Payer BA; Schwabl P; Steiner S; Ferlitsch A; Aichelburg MC; Stättermayer AF; Ferenci P; Obermayer-Pietsch B; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T
    Liver Int; 2015 Mar; 35(3):876-85. PubMed ID: 24905495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection.
    Ali M; Yopp A; Gopal P; Beg MS; Zhu H; Lee W; Singal AG
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):295-300. PubMed ID: 26305067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.
    Martinez-Sierra C; Arizcorreta A; Díaz F; Roldán R; Martín-Herrera L; Pérez-Guzmán E; Girón-González JA
    Clin Infect Dis; 2003 Feb; 36(4):491-8. PubMed ID: 12567308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
    Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
    J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.
    Rafi H; Kabbaj N; Salihoun M; Amrani L; Acharki M; Guedira M; Nya M; Amrani N
    Arab J Gastroenterol; 2011 Sep; 12(3):136-8. PubMed ID: 22055591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.
    Poynard T; Bedossa P; Opolon P
    Lancet; 1997 Mar; 349(9055):825-32. PubMed ID: 9121257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.
    Kielland KB; Delaveris GJ; Rogde S; Eide TJ; Amundsen EJ; Dalgard O
    J Hepatol; 2014 Feb; 60(2):260-6. PubMed ID: 24096048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
    Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
    Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.